Core Viewpoint - The bio-based 1,3-propanediol (PDO) industry in China is transitioning from "technology validation" to "scale production" by 2025, driven by the demand for green transformation in downstream markets such as textiles and cosmetics [2]. Group 1: PDO Production Capacity and Technological Advances - By 2025, multiple companies are accelerating the construction of large-scale production bases for bio-based PDO, with significant investments and technological breakthroughs [4][5]. - Companies like Qingda Zhixing and Heng Carbon Technology have successfully developed fermentation methods for PDO production, breaking the technological monopoly of foreign firms [5][6]. - Heng Carbon Technology has established a unique production base with an annual capacity of 15,000 tons, utilizing a revolutionary "three non-four no" technology that is highly environmentally friendly [6][7]. Group 2: Market Expansion and Applications - PDO is widely applicable in various industries, including polyester, cosmetics, polyurethane, pharmaceuticals, and coatings [10]. - The global bio-based PTT market, which utilizes PDO as a core monomer, is projected to grow from approximately 3.4 billion yuan in 2023 to 8.3 billion yuan by 2030, with a compound annual growth rate of 13.1% [13]. - Companies are forming strategic partnerships to create integrated industrial bases that enhance competitiveness in the bio-based PTT market [13][14]. Group 3: Emerging Companies and Innovations - New companies are emerging with innovative production techniques, such as Shandong Xiangchi Jianyuan Biotechnology, which is implementing advanced fermentation methods to enhance production efficiency [9]. - Zhongke Baiyijin has successfully produced bio-based PDO with a purity of 99.9% using biomass as a raw material [9]. - The industry is witnessing a structural expansion in downstream markets, particularly in textiles and cosmetics, benefiting from reduced raw material costs and increased production capacity [14].

天眼查App显示，近日，九尖蕲艾（深圳）科技有限公司成立，法定代表人为林镇鹏，注册资本10万人 民币，经营范围为一般经营项目是：生物化工产品技术研发；组织文化艺术交流活动；健康咨询服务 （不含诊疗服务）；养生保健服务（非医疗）；日用品批发；日用品销售；化妆品批发；化妆品零售； 品牌管理；电子产品销售；食品销售（仅销售预包装食品）；食品互联网销售（仅销售预包装食品）； 农副产品销售；食用农产品初加工；教育咨询服务（不含涉许可审批的教育培训活动）；招生辅助服 务；业务培训（不含教育培训、职业技能培训等需取得许可的培训）；技术服务、技术开发、技术咨 询、技术交流、技术转让、技术推广。（除依法须经批准的项目外，凭营业执照依法自主开展经营活 动），许可经营项目是：无。 ...

Core Viewpoint - Nanjing Licheng Biotechnology Co., Ltd. has been established with a registered capital of 500,000 RMB, focusing on various sectors including biotechnology, new materials, and daily chemical products [1] Company Overview - The legal representative of Nanjing Licheng Biotechnology Co., Ltd. is Zhang Yihong [1] - The company has a registered capital of 500,000 RMB [1] Business Scope - The company’s business activities include research and development of biochemical products, new materials technology, and manufacturing of daily chemical products [1] - It also engages in the sale of daily necessities, disinfectants, personal hygiene products, and cosmetics [1] - Additional services include general cargo storage, transportation packaging, and handling [1]

Core Viewpoint - The announcement indicates that Jiangsu Lanfeng Biochemical Co., Ltd., a subsidiary of Lanfeng Biochemical, will receive a capital increase of 30 million yuan from one of its original shareholders, Yuanjiang Bide Chemical Co., Ltd. [1] Group 1 - The capital increase consists of 3 million yuan added to registered capital and 27 million yuan added to capital reserves [1] - Other original shareholders of Lanfeng Biochemical plan to waive their preemptive rights to the capital increase [1] - After the capital increase, the registered capital of Lanfeng Biochemical will rise from 130 million yuan to 133 million yuan, and the company's ownership stake in Lanfeng Biochemical will decrease from 76.92% to 75.19% [1]

Core Insights - A new company, Suqian Mairilin Biotechnology Co., Ltd., has been established with a registered capital of 1 million RMB [1] Company Overview - The legal representative of the company is Li Hao [1] - The business scope includes general projects such as: - Research and development of biochemical products - Retail of cosmetics - Sales of daily necessities - Retail of clothing and accessories - Sales of arts and crafts and ceremonial supplies (excluding ivory and its products) - Sales of electronic products - Sales of daily chemical products - Wholesale of cosmetics - Sales of personal hygiene products - Sales of daily miscellaneous items - Internet sales (excluding goods that require permits) [1]

Core Viewpoint - Guangdong Jingqu Biotechnology Co., Ltd. has been established with a registered capital of 5 million RMB, focusing on various biotechnology and chemical product services [1] Group 1: Company Overview - The company is engaged in the research and development of biochemical products and the manufacturing of daily chemical products [1] - It offers a wide range of services including technical services, development, consulting, and technology transfer [1] - The company is involved in the production and sales of various chemical products, cosmetics, and specialized chemical products, excluding hazardous chemicals [1] Group 2: Business Scope - The business scope includes manufacturing and sales of daily chemical products, personal hygiene products, disinfectants, and household goods [1] - The company also engages in domestic trade agency, trade brokerage, and internet sales, along with packaging services and advertising [1] - It has specific licensed projects for the production of sanitary products and disinfectants, which require approval from relevant authorities [1]

Core Viewpoint - Guangdong Shangde Biotechnology Co., Ltd. has been established with a registered capital of 5 million RMB, focusing on various food and feed production and sales activities [1] Group 1: Company Overview - The company is registered with a capital of 5 million RMB [1] - Its business scope includes food production, food sales, feed production, and food additive production [1] - The company is also involved in the research and development of biological chemical products and bio-feed [1] Group 2: Business Activities - The company engages in a wide range of activities including technology services, technical consulting, and technology transfer [1] - It sells various products such as pet food, agricultural products, and health foods [1] - The company is involved in the sales of industrial animal fats and non-edible plant oils [1] Group 3: Regulatory Compliance - The company will conduct its operations in accordance with relevant approvals and permits required by authorities [1] - Specific business activities are subject to approval from relevant departments [1]

Group 1 - Zhengzhou will host three recruitment fairs, providing over 20,000 job positions across various regions, industries, and demographics [1] - The recruitment fairs will feature a combination of job matching, skills training, and unique empowerment activities to create a multi-layered employment service platform for job seekers [1][2] - The first recruitment fair on December 10 will offer more than 8,700 job positions from well-known companies in sectors such as manufacturing, biotechnology, information technology, and food processing [1][2] Group 2 - The recruitment fairs will include special activities like a short drama actor audition and hand-knitting training to enhance the appeal and effectiveness of the events [2] - The second recruitment fair on December 11 will focus on high-level talents and recent graduates, providing over 6,600 job positions in various fields including finance, education, and healthcare [3][4] - The third recruitment fair on December 13 will be held for key enterprises, further expanding job opportunities for job seekers [3][4] Group 3 - The job positions available will cover a wide range of professional categories, including software development, project management, and marketing, totaling over 9,900 positions [4] - The recruitment fairs will feature dedicated areas for company recruitment and displays, along with mobile services for easy resume submission [5]

天眼查App显示，近日，宿州科蔺生物科技有限公司成立，法定代表人为李琼，注册资本30万人民币， 经营范围为许可项目：卫生用品和一次性使用医疗用品生产；食品用洗涤剂生产；建筑劳务分包（依法 须经批准的项目，经相关部门批准后方可开展经营活动，具体经营项目以相关部门批准文件或许可证件 为准）一般项目：生物化工产品技术研发；技术服务、技术开发、技术咨询、技术交流、技术转让、技 术推广；化工产品生产（不含许可类化工产品）；基础化学原料制造（不含危险化学品等许可类化学品 的制造）；专用化学产品制造（不含危险化学品）；日用化学产品制造；化工产品销售（不含许可类化 工产品）；食品用洗涤剂销售；个人卫生用品销售；日用品销售；专用化学产品销售（不含危险化学 品）；日用化学产品销售；日用百货销售；日用杂品制造；日用杂品销售；消毒剂销售（不含危险化学 品）；专业保洁、清洗、消毒服务；美发饰品销售；卫生用品和一次性使用医疗用品销售；化妆品零 售；办公用品销售（除许可业务外，可自主依法经营法律法规非禁止或限制的项目）。 ...

Core Insights - The European Commission has officially released a new bioeconomy strategy framework, focusing on "competitiveness + sustainability" as dual core objectives aimed at accelerating the circular economy and decarbonization while reducing dependence on imported fossil fuels [1] - The strategy identifies ten core application areas for bio-based materials and technologies, covering end products such as plastics, textiles, and chemicals, as well as key technological directions like biorefining, advanced fermentation, and permanent storage of biochar [1] - The bioeconomy is seen as a crucial pathway for Europe to enhance economic resilience and replace fossil-based products, supporting 17.1 million jobs and positioning Europe to capture a leading role in the global clean industry [1] Industry Developments - The bioeconomy in the EU has reached a scale of €2.7 trillion in 2023, with expanding application scenarios including bio-based chemicals from algae serving the pharmaceutical and daily chemical sectors, and bio-based plastics gradually replacing traditional materials in packaging and automotive parts [1] - The strategy aims to achieve three goals: enhancing resilience, increasing competitiveness, and protecting the ecosystem, with a commitment to ensuring that natural ecology remains the foundation of economic development [1] Implementation Framework - To unlock potential, the EU has established a three-dimensional implementation system of "regulation + funding + market": simplifying regulatory frameworks to incentivize sustainable business models while ensuring safety, guiding EU finances towards bio-based technologies, and setting demand targets through legislation [2] - The establishment of the "European Bio-based Alliance" aims to facilitate collective procurement of €10 billion in bio-based solutions by 2030 [2] - Industry responses have been positive, with calls for a specialized legal framework and market premium mechanisms for low-carbon products, emphasizing the need for stronger policy guidance to accelerate the commercialization of innovative results [2]